Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CartiLife vs Microfracture for Knee Chondral Defects
NCT03545269Phase 2Completed
- Sponsor
- Biosolution Co., Ltd.
- Start
- Feb 2014
- Primary completion
- Feb 2017
- Modality
- Tissue Cells
01
Overview
Phase 2, randomised, open-label trial of CartiLife in articular cartilage lesion of the knee (2 arms), sponsored by Biosolution Co., Ltd. Primary endpoint: Magnetic Resonance Observation of Cartilage Repair Tissue at 48 weeks. Started Feb 2014; status: completed.
02
Drugs
CartiLife
03
Conditions
articular cartilage lesion of the knee
Beyond the preview
Go deeper on NCT03545269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03545269.